Drug delivery technology has witnessed a number of advancements purported to cater to the customized needs of its ultimate beneficiaries—the patients. Nowadays, dosage forms are not confined to conventional tablets, capsules or injectables, but have evolved to cover novel drug carriers such as particulates, vesicles and many others. Nanotechnological advancements have played a major role in this paradigm shift in ways of delivering active pharmaceutical ingredients; as researchers across the globe continue striving to provide site-specific (targeted) drug in the treatment of diseases.